US FDA outlines regulatory science strategy
This article was originally published in Scrip
Executive Summary
The US FDA last week unveiled its comprehensive plan to update the applied science used in developing the tools, standards and approaches for assessing the safety, efficacy quality, and performance of FDA-regulated products, including prescription drugs.